HB457 Alabama 2018 Session

Summary

Primary Sponsor

Elaine Beech

Democrat

Session

Regular Session 2018

Title

Pharmacies, pharmacy records, auditing procedures, further provided for, recoupment limited under certain conditions, Secs. 34-23-181, 34-23-183, 34-23-184, 34-23-185, 34-23-186 am'd.

Summary

HB 457 tightens pharmacy record audits and limits recoupment for certain errors to protect pharmacies while ensuring proper claims review.

What This Bill Does

The bill expands and clarifies auditing procedures for pharmacy records, requires advance notice for on-site audits, and ensures professional judgment by licensed pharmacists in clinical parts of audits. It limits recoupment for clerical or record-keeping errors that do not harm patients or funds, allows amended claims, and restricts use of extrapolation in calculating penalties. It also creates a formal appeals process, prohibits penalties without proof of fraud intent, and sets timelines and conditions for final audit reporting and possible withholdings when large discrepancies occur.

Who It Affects

• Pharmacies and pharmacists, who will be audited under clearer rules, with protections against treating clerical errors as fraud and with defined limits on recoupment.
• Health benefit plans, pharmacy benefit managers, insurers, and Medicaid, which must follow new audit procedures, reporting, and dispute resolution requirements.
• Patients/consumers, who gain protections from inappropriate recoupment and can pursue amended claims or appeals if errors occurred.

Key Provisions

• Defines health benefit plans, pharmacies, and pharmacy benefit managers to clarify who is covered by the auditing rules.
• Auditing rules require written audit procedures in contracts, at least two weeks' notice for on-site audits, and documentation of audit items provided to the pharmacy.
• Audits involving clinical judgments must be conducted with input from a licensed pharmacist; clerical or record-keeping errors are not fraud, and recoupment is limited to actual overpayments or harm caused.
• No extrapolation may be used to calculate recoupments or penalties, except as federal law may require; penalties cannot be based on an assumed error beyond reviewed claims.
• Sample size for audits is capped at 150 prescriptions; costs of audits are generally borne by the auditing entity unless Medicaid rules apply for larger samples.
• Final audit timelines include preliminary reports within 90 days, at least 30 days for response, and final reports within 180 days; interest does not accrue during audits.
• Pharmacies may appeal unfavorable preliminary findings; mediation is available if issues remain unresolved after appeal.
• If a discrepancy exceeds $25,000, future payments may be withheld pending finalization of the audit.
• Disallowance of compensation to auditing staff based on amounts claimed or recouped.
• Auditing period is limited to two years, and audits cannot be initiated during the first five days of any month.

AI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Pharmacies and Pharmacists